These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
78 related items for PubMed ID: 22401633
21. The re-emergence of tuberculosis. Porter JD, McAdam KP. Annu Rev Public Health; 1994; 15():303-23. PubMed ID: 8054087 [Abstract] [Full Text] [Related]
24. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. API Consensus Expert Committee. J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350 [Abstract] [Full Text] [Related]
25. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases. Tabarsi P, Chitsaz E, Tabatabaei V, Baghaei P, Shamaei M, Farnia P, Marjani M, Kazempour M, Mansouri D, Masjedi MR, Velayati AA. Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008 [Abstract] [Full Text] [Related]
26. Effectiveness of anti-tuberculosis treatment among patients receiving highly active antiretroviral therapy at Vihiga district hospital in 2007. Kwange SO, Budambula NL. Indian J Med Microbiol; 2010 Sep; 28(1):21-5. PubMed ID: 20061758 [Abstract] [Full Text] [Related]
32. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis]. Kang WL, Xie YG, Tan WG, Chu NH, Li L, You YH, Yang YZ, Wang XM, Yan XL, Miao ZP, Duanmu HJ. Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883 [Abstract] [Full Text] [Related]
33. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia. Elliott AM, Halwiindi B, Hayes RJ, Luo N, Mwinga AG, Tembo G, Machiels L, Steenbergen G, Pobee JO, Nunn PP. J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484 [Abstract] [Full Text] [Related]
35. Prevalence of acquired MDR-TB and HIV co-infection. Deivanayagam CN, Rajasekaran S, Venkatesan R, Mahilmaran A, Ahmed PR, Annadurai S, Kumar S, Chandrasekar C, Ravichandran N, Pencillaiah R. Indian J Chest Dis Allied Sci; 2002 Feb; 44(4):237-42. PubMed ID: 12437236 [Abstract] [Full Text] [Related]
36. Multidrug-resistant tuberculosis in an HIV-infected girl. Shah I, Mohanty S. Natl Med J India; 2012 Feb; 25(4):210-1. PubMed ID: 23278778 [Abstract] [Full Text] [Related]
37. The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa. Seddon JA, Hesseling AC, Marais BJ, Jordaan A, Victor T, Schaaf HS. Int J Tuberc Lung Dis; 2012 Jul; 16(7):928-33. PubMed ID: 22583610 [Abstract] [Full Text] [Related]
38. Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay. Shah NS, Moodley P, Babaria P, Moodley S, Ramtahal M, Richardson J, Heysell S, Li X, Moll A, Friedland G, Sturm AW, Gandhi NR. Am J Respir Crit Care Med; 2011 May 15; 183(10):1427-33. PubMed ID: 21297071 [Abstract] [Full Text] [Related]
39. Clinical characteristics and treatment outcomes among patients with tuberculosis in Bangkok and Nonthaburi, Thailand. Manosuthi W, Kawkitinarong K, Suwanpimolkul G, Chokbumrungsuk C, Jirawattanapisal T, Ruxrungtham K, Akksilp S. Southeast Asian J Trop Med Public Health; 2012 Nov 15; 43(6):1426-36. PubMed ID: 23413706 [Abstract] [Full Text] [Related]